ACMD meeting statement, Meeting 41, 28 June 2018
Advisory Committee on Medical Devices
Role of the ACMD in the TGA's regulatory decision making process
The Advisory Committee on Medical Devices (ACMD) is a statutory advisory committee established by the Therapeutic Goods Regulations 1990. The committee provides independent expert advice on specific scientific and technical matters in order to aid the TGA's decision making and other regulatory processes.
While the advice provided by the ACMD is an important element in the undertaking of the TGA's regulatory functions it forms only part of the information that is available to delegates when they make a regulatory decision under the Therapeutic Goods Act 1989. It is important to note that while appropriate consideration will always be given to such advice, the TGA is not obliged to follow the specific recommendations and advice given by the committee.
It should also be noted that information about advice provided by the committee may not become publicly available for some time after the committee has provided that advice. The purpose of this Meeting Statement is to describe in general terms the matters considered by the committee at each meeting and for it to be available as soon as reasonably practical after the relevant meeting.
Update on matters where the committee previously provided advice and a TGA decision has been made
The following updates for items considered by the committee at ACMD 39 were provided:
An implantable knee prosthesis system has been included in the Australian Register of Therapeutic Goods (ARTG).
Components of a hip prosthesis system for revision surgeries have been included in the ARTG.
Overview of the medical devices referred for advice
At the 41st ACMD meeting the committee considered the following devices:
- An implantable tissue oxygenation monitor,
- An implantable intraocular telescope for treating macular degeneration, and
- An electrophysiology catheter with reuse functionality.
The committee considered whether the benefits outweighed the risks for the devices and whether adequate evidence has been provided to demonstrate safety and performance through compliance with the Essential Principles.
Meeting statements are made publicly available after each meeting.